ARCHIVES

Faulding, NaPro In Agreement For Marketing Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

In Brief: Twenty Apply for ICC Director Job, DeVita Says 30 More Centers Needed; PAP Awards To Clark, Fox

March 18, 1983

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

November 15, 2013